29/10/2024
All three medicines are approved for weight loss by the MHRA. Ozempic and Wegovy contain an active ingredient called semaglutide which works with the GLP-1 receptor. In the case of Mounjaro, the active ingredient is tirzepatide which acts on both GLP-1 and the GIP receptors. This combination effect on receptors has shown to be more effective than the drugs that work on the GLP-1 receptor alone.
1 out of 1 found this helpful